Patent directory · USPTO A61K / A61P
Patents matching “anti-”
1,068 pharma patents match "anti-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,068 pharmaceutical patents matching "anti-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11104729
Anti-IL-33 antibodies and uses thereof
granted -
US 11103472
Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)
granted -
US 11098112
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11098311
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11098127
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 11098131
Anti-EpCAM antibodies, compositions comprising anti-EpCAM antibodies and methods of making and using anti-EpCAM antibodies
granted -
US 11098126
Anti-MET antibodies and uses thereof
granted -
US 11098109
Single-chain variable fragment anti-CD133 antibodies and uses thereof
granted -
US 11096927
Anti-flavivirus compounds and methods of use
granted -
US 11091555
Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy
granted -
US 11091472
PI-kinase inhibitors with anti-infective activity
granted -
US 11086049
Anti-microbial bandage contact lens with ocular drug delivery
granted -
US 11077068
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
granted -
US 11077182
Methods of preparing anti-human papillomavirus antigen T cells
granted -
US 11078266
Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3
granted -
US 11072639
Bi-functional anti-tau polypeptides and use thereof
granted -
US 11072656
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof
granted -
US 11066378
Caffeic acid derivatives for anti-angiogenesis
granted -
US 11066474
Anti-TrkB monoclonal antibodies and methods of use
granted -
US 11058664
In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumors
granted -
US 11059896
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11058802
Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
granted -
US 11059906
Anti-CCL2 and anti-LOXL2 combination therapy for treatment of scleroderma
granted -
US 11053280
Anti-VEGF protein compositions and methods for producing the same
granted